CXCR4 antagonist AMD3100 enhances therapeutic efficacy of transcatheter arterial chemoembolization in rats with hepatocellular carcinoma

Abstract This study aims to discover the therapeutic effect of chemokine (CXC motif) receptor 4 (CXCR4) antagonist AMD3100 combined with transcatheter arterial chemoembolization (TACE) in a rat model with hepatocellular carcinoma (HCC). An orthotopic model of HCC was established and treated with T...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Hong‐Wei Lei, Bi‐Run Huang, Jie Cai, Cheng‐Ming Li, Chun‐Bo Shang, Zhi‐Yang Liao, Zheng‐Dong Wan
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2022-08-01
Serie:	Kaohsiung Journal of Medical Sciences
Soggetti:	AMD3100 CXCR4 hepatocellular carcinoma transcatheter arterial chemoembolization
Accesso online:	https://doi.org/10.1002/kjm2.12540
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!